Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans

Infection and Immunity

Volumn 65, Issue 3, 1997, Pages 903-908

  Levitz, Stuart M ^a   North, Eleanor A ^a   Jiang, Yanling ^a   Nong, Shu Hua ^a   Kornfeld, Hardy ^a   Harrison, Thomas S ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHEMOTAXIS; CRYPTOCOCCUS NEOFORMANS; DISEASE ASSOCIATION; GENE INDUCTION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; PHAGOCYTOSIS; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0031035717     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.3.903-908.1997     Document Type: Article

References (42)

1. Antoniades, H. N., J. Neville-Golden, T. Galanopoulos, R. L. Kradin, A. J. Valente, and D. T. Graves. 1992. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic fibrosis. Proc. Natl. Acad. Sci. USA 89:5371-5375.
2. Baggiolini, M., P. Loetscher, and B. Moser. 1995. Interleukin-8 and the chemokine family. Int. J. Immunopharmacol. 17:103-108.
3. Becker, S., J. Quay, H. S. Koren, and J. S. Haskill. 1994. Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am. J. Physiol. 266: L278-L286.
4. Cameron, M. L., D. L. Granger, J. B. Weinberg, W. J. Kozumbo, and H. S. Koren. 1990. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am. Rev. Respir. Dis. 142:1313-1319.
5. Cherniak, R., L. C. Morris, T. Belay, E. D. Spitzer, and A. Casadevall. 1995. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect. Immun. 63:1809-1905.
6. Chuck, S. L., and M. A. Sande. 1989. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Engl. J. Med. 321: 794-799.
7. + T cells. Science 270:1811-1815.
8. Diamond, R. D. 1995. Cryptococcus neoformans. p. 2331-2340. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Manuell, Douglas and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone Inc., New York, N.Y.
9. Diamond, R. D., and N. F. Erickson. 1982. Chemotaxis of human neutrophils and monocytes induced by Cryptococcus neoformans. Infect. Immun. 38:380-382.
10. Dong, Z. M., and J. W. Murphy. 1993. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect. Immun. 61:5067-5077.
11. Dong, Z. M., and J. W. Murphy. 1995. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect. Immun. 63:770-778.
12. Dong, Z. M., and J. W. Murphy. 1996. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J. Clin. Invest. 97:689-698.
13. Friedland, J. S., R. J. Shattock, and G. E. Griffin. 1993. Phagocytosis of Mycohacterium tuberculosis or paniculate stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene expression. Cytokine 5:150-156.
14. Granger, D. L., J. R. Perfect, and D. T. Durack. 1985. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J. Clin. Invest. 76:508-516.
15. Graves, D. T., and Y. Jiang. 1995. Chemokines, a family of chemotactic cytokines. Crit. Rev. Oral Biol. Med. 6:109-118.
16. Harrison, T. S., H. Kornfeld, and S. M. Levitz. 1995. The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes. J. Infect. Dis. 172:665-671.
17. Harrison, T. S., and S. M. Levitz. 1996. Role of IL-12 in PBMC responses to fungi in persons with and without HIV infection. J. Immunol. 156:4492-4497.
18. Hogan, L. H., B. S. Klein, and S. M. Levitz. 1996. Virulence factors of medically important fungi. Clin. Microbiol. Rev. 9:469-488.
19. + T cells during a pulmonary Cryptococcus neofonnans infection. J. Immunol. 155:4790-4797.
20. Jacobson, E. S., and H. S. Emery. 1991. Temperature regulation of the cryptococcal phenoloxidase. J. Med. Vet. Mycol. 29:121-124.
21. Jiang, Y., T. R. Russel, D. T. Graves, H. Cheng, S.-H. Nong, and S. M. Levitz. 1996. Monocyte chemoattractant protein 1 and interleukin-8 production in mononuclear cells stimulated by oral microorganisms. Infect. Immun. 64: 4450-4455.
22. Kozel, T. R., G. S. Pfronimer, A. S. Guerlain, B. A. Highison, and G. J. Highison. 1988. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect. Immun. 56:2794-2800.
23. Kwon-Chung, K. J., I. Polacheck, and T. J. Popkin. 1982. Melanin-lacking mutants of Cryptococcus neofonnans and their virulence for mice. J. Bacteriol. 150:1414-1421.
24. Laxalt, K. A., and T. R. Kozel. 1979. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neofonnans. Infect. Immun. 26:435-440.
25. Levitz, S. M. 1991. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev. Infect. Dis. 13:1163-1169.
26. Levitz, S. M. 1994. Macrophage Cryptococcus interactions, p. 533-543. In B. S. Zwilling and T. K. Eisenstein (ed.), Macrophage pathogen interactions. Marcell Dekker. Inc., New York, N.Y.
27. Levitz, S. M., and D. J. DiBenedetto. 1989. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J. Immunol. 142:659-665.
28. Levitz, S. M., and E. A. North. 1996. Unpublished data.
29. Levitz, S. M., A. Tabuni, H. Kornfeld, C. C. Reardon, and D. T. Golenbock. 1994. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neofonnans. Infect. Immun. 62:1975-1981.
30. Levitz, S. M., A. Tabuni, S.-H. Nong, and D. T. Golenbock. 1996. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neofonnans, Candida albicans, and lipopolysaccharide. Infect. Immun. 64:945-951.
31. + T lymphocytes. FASEB J. 8:1055-1060.
32. Macher, A. B., J. E. Bennett, J. E. Gadek, and M. M. Frank. 1978. Complement depletion in cryptococcal sepsis. J. Immunol. 120:1686-1690.
33. Miller, M. F., and T. G. Mitchell. 1991. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect. Immun. 59:24-28.
34. Mitchell, T. G., and L. Friedman. 1972. In vitro phagocytosis and intracellular late of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5:491-498.
35. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1995. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect. Immun. 63:3353-3359.
36. Small, J. M., and T. G. Mitchell. 1989. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A. Infect. Immun. 57:3751-3756.
37. Taub, D. D., P. Proost, W. J. Murphy, M. Amer, D. L. Longo, J. van Damme, and J.J. Oppenheim. 1995. Monocyte chemotactic protein-1 (MCP-1), -2. and -3 are chemotactic for human T lymphocyte. J. Clin. Invest. 95:1370-1376.
38. Truelsen, K., T. Young, and T. R. Kozel. 1992. In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans. Infect. Immun. 60:3937-3939.
39. Vartivarian, S. E., E. J. Anaissie, R. E. Cowart, H. A. Sprigg, M. J. Tingler, and E. S. Jacobson. 1993. Regulation of cryptococcal cupsular polysaccharide by iron. J. Infect. Dis. 167:186-190.
40. Wagner, R. P., S. M. Levitz, A. Tabuni, and H. Kornfield. 1992. HIV-1 envelope protein (gp120 inhibits the activity of human bronchoalveolar macrophages against Cryptococcus neoformans. Am. Rev. Respir. Dis. 146: 1434-1438.
41. Yano, S., H. Yanagawa, Y. Nishioka, N. Mukaida, K. Mutsushima, and S. Sone. 1996. T helper cyotokines differentlyy regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J. Immunol. 157:2660-2665.
42. Yoshimura, T., M. Takeya, K. Takahashi, J. Kuratsu, and E. J. Leonard. 1991. Production and characterization of mouse monoclonal antibodies against human monocyte chemoattractant protein-1. J. Immunol. 147:2229-2233.